Watch the highlights of CSF Course Director, Joel Schlessinger, MD‘s Q & A session with the “Skin Cancer Epidemic: Mohs Update” panelists on some of the controversies related to skin cancer treatments: the expansion of XRT and the increasing number of biopsies by non-dermatologists.
Tags
Skin Cancer Epidemic: Mohs Updatecontroversies in Skin Cancer Treatmentsincreasing number of biopsies by non-dematologistsuse of XRT in private practiceAAD physician statementbiopsy ten or more lesionsprioritizing biopsy sites and treatCosmeticsENTOculoplasticCME Accreditationmedicaltraditional dermatologypracticalhonestinsightfuldiscussion basedbiopsiescosmetic surgeryCosmetic Surgery ForumdermatologyfeatureJoel SchlessingerM. Laurin Councilmohsmohs surgeryMurad AlamPlastic SurgeryQ&ARhett Druggeskin cancerskin cancer treatmentsXRT
Latest Posts
-
Everything NEW! you need to know about the 2022 Cosmetic Surgery Forum
- October 31, 2022
-
CSF Virtual Town Hall: COVID-19 and Fillers
- January 13, 2021
-
Expanding on Advanced Laser Techniques for Specific Skin Conditions
- November 24, 2020
-
Hormones and Dermatology Part 2: Use of Emepelle in Preventing and Treating of Estrogen-Deficient Skin
- November 6, 2020
-
Navigating Patient Care in 2020: Expert Tips for In-Person and Virtual Patient Consultations
- October 23, 2020
Leave a Comment